Finance

Lists
ZYBT:NASDAQ
Zhengye Biotechnology Holding Ltd
USD 1,22
+1,67%
(+0,020) 1D
1 Okt., 12:30:49 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZYBT...
Open
USD 1,20
High
USD 1,29
Low
USD 1,20
Mkt. cap
36,26 m
Avg. vol.
102,82 k
Volume
13,28 k
52-wk high
USD 8,01
52-wk low
USD 0,62
EPS
-USD 0,22
Shares outstanding
10,96 m
No. of employees
269
Open
USD 1,20
High
USD 1,29
Low
USD 1,20
Mkt. cap
36,26 m
Avg. vol.
102,82 k
Volume
13,28 k
52-wk high
USD 8,01
52-wk low
USD 0,62
EPS
-USD 0,22
Shares outstanding
10,96 m
No. of employees
269
News stories
From web sources and news partners
About Zhengye Biotechnology Holding Ltd
CEO-
Employees269
Founded2004
Headquarters-
SectorPharmaceutical industry
Websitejlzybio.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
31,16 m
31,16 m
27,02 m
27,02 m
Cost of goods sold
21,47 m
21,47 m
24,77 m
24,77 m
Cost of revenue
21,47 m
21,47 m
24,77 m
24,77 m
Research and development expenses
4,48 m
4,48 m
4,52 m
4,52 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,01 m
20,01 m
17,46 m
17,46 m
Operating expense
24,13 m
24,13 m
23,06 m
23,06 m
Total operating expenses
45,60 m
45,60 m
47,83 m
47,83 m
Operating income
-14,44 m
-14,44 m
-20,81 m
-20,81 m
Other non operating income
545,00 k
545,00 k
516,00 k
516,00 k
EBT including unusual items
-15,44 m
-15,44 m
-20,49 m
-20,49 m
EBT excluding unusual items
-15,44 m
-15,44 m
-20,56 m
-20,56 m
Income tax expense
-2,67 m
-2,67 m
8,22 m
8,22 m
Effective tax rate
17,29%
17,29%
-40,10%
-40,10%
Other operating expenses
-
-
-
-
Net income
-10,83 m
-10,83 m
-24,06 m
-24,06 m
Net profit margin
-34,76%
-34,76%
-89,05%
-89,05%
Earnings per share
-
-
-
-
Interest and investment income
36,00 k
36,00 k
12,00 k
12,00 k
Interest expense
-876,00 k
-876,00 k
-824,00 k
-824,00 k
Net interest expenses
-840,00 k
-840,00 k
-812,00 k
-812,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,31 m
-8,31 m
-14,00 m
-14,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme